Paul Shapiro

SWMF Life Science Venture Fund LP invests in life science and medical device companies located in Southwest Michigan. It provides financing for start-up and early stage capital requirements.

CTBC Bank Co. Ltd. engages in the provision of banking services. It operates through the following segments: Institutional Banking, Retail Banking, and Other segments. The Institutional Banking segment includes commercial banking and capital market activities. The Retail Banking segment offers clients with financial services such as wealth management, credit cards, secured loans, and unsecured individual loans. The Other segment involves in the investing and general administration. The company was founded on March 14, 1966 and is headquartered in Taipei, Taiwan.

Zurich Insurance Co. Ltd. engages in the provision of life and general insurance. It offers insurance products on motor vehicles, travel, retirement, and protection. It caters to individuals, small-and-medium business enterprise, and corporations. The company was founded in 1872 and is headquartered in Zurich, Switzerland.

Zurich Life Assurance Plc (Zurich Life) is the Ireland-based life insurance subsidiary of Zurich Holding Ireland Ltd., ultimately held by Zurich Insurance Group AG (SWX: ZURN) in Switzerland. Founded in 1977, the firm was formerly known as Eagle Star Life Assurance Co. of Ireland Ltd. In 1984, Eagle Star Insurance Group was acquired by BAT Industries and in 1997 BAT's financial services businesses were spun off and merged with Zurich Insurance Co. to create Zurich Financial Services Group. Eagle Star Life Assurance was rebranded Zurich Life Ireland in 2008 and subsequently became Zurich Life Assurance Plc. Headquartered in Dublin, Zurich Life provides a wide range of property and casualty, and life insurance products and services to individuals, small businesses, and mid-sized and large companies, as well as multinational corporations.

Part of Van Lanschot Kempen NV, Van Lanschot Kempen Wealth Management NV provides investment banking services. The company is based in 's-Hertogenbosch, Netherlands. Kallol Karl Guha has been the CEO of the Dutch company since 2013.

Central Hockey League operates a professional minor league hockey teams playing in small to medium-sized markets primarily in central and southwestern US states. The league, which was started in 1992, is managed and operated by WPHL, a subsidiary of Global Entertainment Corporation.

Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom.

Founded in 1935, Glaxo Group Ltd. is a subsidiary of GSK Plc. The company is based in Middlesex, UK. At GSK, we unite science, technology and talent to get ahead of disease together.

Linköping University Hospital provides healthcare services.

KPMG Accountants NV provides accounting services. The company was founded in 2008 and is headquartered in Enschede, the Netherlands.

Archimedes Pharma UK Ltd. involves in marketing niche pharmaceutical products. The company is headquartered in London, the United Kingdom.

The National Center for Missing & Exploited Children, Inc. helps in the prevention of abducted, endangered, and sexually exploited children. Its services include offering information about missing and exploited children. The company was founded by John Walsh and Rev? Walsh in January 1984 and is headquartered in Alexandria, VA.

S*BIO is a privately-held biotech company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer with leading programs around histone deacetylases (HDAC) and kinases. S*BIO's lead candidate, SB939, entered the clinic in 2007. SB1518, S*BIO's potent and orally-active JAK2 inhibitor, entered the clinic in 2008 and has received orphan drug designation from the U.S. FDA. S*BIO has entered into a development collaboration, and option & license agreement with Onyx Pharmaceuticals, Inc. to develop and commercialize SB1518 and its other novel JAK2 inhibitor, SB1578. S*BIO's SB1317, a novel multikinase inhibitor, is in pre-clinical development and under a worldwide exclusive license with Tragara Pharmaceuticals, Inc. for its development and commercialization. In line with its vision to be a leading fully-integrated oncology-focused biotech company in Asia Pacific, S*BIO has established a state-of-the-art R&D infrastructure, complemented by a strong clinical development team. S*BIO has strong links with a network of medical oncologists in Asia Pacific and its investors include EDB Investments' biomedical sciences subsidiary Bio*One Capital, Aravis Ventures, Novartis Bioventures and other international funds. In 2009, S*BIO received the BioSpectrum Editor's Choice, Emerging BioScience Company of Singapore Award.

KPMG Europe LLP provides financial services. It offers audit and assurance, business technology, deal advisory, legal services, management consulting, pensions, risk consulting, tax, and strategy. The company was founded in 1907 and is headquartered in London, the United Kingdom.

Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark.

Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek is a scientific research institute and a specialist clinic. The firm’s areas of research are including fundamental, clinical and translational cancer research. The company was founded in 1916 and is headquartered in Amsterdam, Netherlands.

The American College of Rheumatology is an organization for physicians and health professionals. The non-profit company is based in Atlanta, GA. The company was founded by Göran Albert Torstensson Ando.

European Financial Services Round Table operates as an association to regulate the financial risks. It specializes in bringing together chairman and chief executives of European banks and insurance companies. The purpose of the EFR is to contribute to the European public policy debate on issues relating to financial services and to the financial stability with the completion of the single market in financial services. The company was founded in 2001 and is headquartered in Brussels, Belgium.

Royal Concertgebouw Orchestra Operates as a symphony orchestra. The company is headquartered in Amsterdam, the Netherlands.

Jazz Pharmaceuticals UK Ltd. is pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, oncology supportive care and critical care products. The company was founded in 2006 and is headquartered in Oxford, United Kingdom.

Zurich Insurance Plc engages in the provision of non-life insurance products and services. Its customers include individuals; small businesses; commercial enterprises; and mid-sized, large, and multinational corporations. The company was founded in 1950 and is headquartered in Dublin, Ireland.

Zurich Insurance Group Ltd. provides insurance products and services. The company was founded on November 26, 1872 and is headquartered in Taipei, Taiwan.